Arcadia Biosciences (RKDA) shares have gained 39% since it reported first-quarter 2024 earnings on May 9. This uptick was driven by the company's sequential and year-over-year revenue growth. Even though it reported a loss from continuing operations, it is at its lowest level in six years. Operating expenses decreased significantly from the previous year, resulting in the fifth consecutive quarter of gross profit margins above 30%. The company reported an adjusted loss of $1.78 per share in the first quarte ...